Harwin Peter Evan 4

4 · Viridian Therapeutics, Inc.\DE · Filed Feb 8, 2021

Insider Transaction Report

Form 4
Period: 2021-02-04
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2021-02-04+25,00025,000 total
    Exercise: $20.50Exp: 2031-02-04Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option vest monthly over a three year period, subject to Reporting Person's continued service on the Board.

Documents

2 files